Maria Engel

Pfizer (United States)

Papers

1

Total Citations

74

H-Index

1

About

Dr. Maria Engel is a leading figure in genetic toxicology, best known for pioneering high-content, high-throughput approaches to genotoxicity screening. Her most influential work, the 2017 paper "Interlaboratory evaluation of a multiplexed high information content in vitro genotoxicity assay" (74 citations), describes a breakthrough multiplexed flow cytometric assay that simultaneously measures p53 activation, γH2AX induction (a marker of DNA double-strand breaks), and phospho-histone H3 (a mitotic marker) in detergent-liberated nuclei. This innovative method dramatically increases the information yield from a single in vitro experiment, moving beyond simple mutation detection to provide mechanistic insights into DNA damage responses. By incorporating internal counting beads for absolute cell quantification, Dr. Engel’s assay enhances reproducibility across laboratories, addressing a critical need in regulatory toxicology. Her work has been instrumental in reducing reliance on animal testing and is widely adopted in pharmaceutical and chemical safety assessment. With a citation record reflecting the field’s high regard for her methodological rigor, Dr. Engel continues to shape the future of genetic toxicology through her commitment to developing more predictive, efficient, and mechanistically informative genotoxicity assays.

Research Focus

Key Achievements

1
H-Index
1
Papers
74
Total Citations
74
Avg Citations/Paper
🏆 Most Cited Paper
Interlaboratory evaluation of a multiplexed high information content in vitro genotoxicity assay
74 citations · 2017
📈 Most Prolific Year: 2017 (1 Papers)
🤝 Key Collaborators: 16
🏛 Institutions: Pfizer (United States)

Top Papers

  1. 1

Key Collaborators

Contact & Links

Available for collaboration
Content generated · 11 days ago